BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03330691-completion@plaintrial.com
DTSTAMP:20261029T110411Z
DTSTART;VALUE=DATE:20350303
SUMMARY:A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CA
 R-T Cell Immunotherapy for CD19+CD22+ Leukemia — estimated completion da
 te
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03330691
URL:https://plaintrial.com/trial/NCT03330691
END:VEVENT
END:VCALENDAR